Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species
Authors
Keywords
-
Journal
JOURNAL DE MYCOLOGIE MEDICALE
Volume 32, Issue 4, Pages 101310
Publisher
Elsevier BV
Online
2022-07-14
DOI
10.1016/j.mycmed.2022.101310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY Program 2016-2018
- (2020) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Susceptibility Tests and the cyp51 Mutant Strains among Clinical Aspergillus fumigatus Isolates from Korean Multicenters
- (2020) Eun Jeong Won et al. MYCOBIOLOGY
- A 9-Year Experience of Aspergillus Infections from Isfahan, Iran
- (2020) Mostafa Chadeganipour et al. Infection and Drug Resistance
- Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of Fusarium and Aspergillus Isolates from Corneal Scrapings
- (2019) Palanisamy Manikandan et al. Biomed Research International
- EUCAST susceptibility testing of isavuconazole: MIC data for contemporary clinical mould and yeast isolates
- (2019) Karin Meinike Jørgensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and antifungal susceptibility profile of Aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies
- (2019) Sung-Yeon Cho et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Molecular identification, antifungal susceptibility testing and mechanisms of azole resistance in Aspergillus spp. received within a surveillance program on antifungal resistance in Spain
- (2019) Olga Rivero-Menendez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017
- (2019) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles
- (2019) Husam Salah et al. Frontiers in Microbiology
- ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter
- (2019) Ikuko Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study
- (2018) S. Imbert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two In Vitro Methods
- (2018) Pavlina Lyskova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- “Emergence of azole resistant Aspergillus fumigatus from immunocompromised hosts in India”
- (2018) Yubhisha Dabas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular identification and susceptibility testing of molds isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 study)
- (2018) Ana Alastruey-Izquierdo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis
- (2018) Alicia López-Sánchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis
- (2018) M. Ghannoum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
- (2018) Laura Bedin Denardi et al. Brazilian Journal of Infectious Diseases
- In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions
- (2018) Hamed Fakhim et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria
- (2018) Cornelia Lass-Flörl et al. INFECTION
- Antifungal susceptibility of clinical isolates of 25 genetically confirmed Aspergillus species collected from Taiwan and Mainland China
- (2018) Ying Li et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates
- (2018) Franqueline Reichert-Lima et al. MYCOSES
- Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
- (2018) Jeffrey D Jenks et al. Drug Design Development and Therapy
- Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species
- (2018) Hsuan-Chen Wang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A. fumigatus
- (2018) Eugénia Pinto et al. Frontiers in Microbiology
- Surveillance for Azole-Resistant Aspergillus fumigatus in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998–2017
- (2018) Alireza Abdolrasouli et al. Frontiers in Microbiology
- Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
- (2018) Eta E Ashu et al. Infection and Drug Resistance
- Changes in the epidemiological landscape of invasive mould infections and disease
- (2017) Cornelia Lass-Flörl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea
- (2017) Eun Jeong Won et al. MEDICAL MYCOLOGY
- In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex
- (2017) Afsane Vaezi et al. MYCOSES
- Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
- (2017) Mahsa Falahatinejad et al. MYCOSES
- Antifungal resistance: current trends and future strategies to combat
- (2017) Nathan Wiederhold Infection and Drug Resistance
- Trends in Hospitalizations related to Invasive Aspergillosis and Mucormycosis in the United States, 2000–2013
- (2017) Snigdha Vallabhaneni et al. Open Forum Infectious Diseases
- Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey
- (2017) Günter Rambach et al. MEDICAL MYCOLOGY
- Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates
- (2017) Eun Jeong Won et al. PLoS One
- Biodegradable functional polycarbonate micelles for controlled release of amphotericin B
- (2016) Ying Wang et al. Acta Biomaterialia
- Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method
- (2016) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)
- (2016) Mariana Castanheira et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus , an opportunistic fungal pathogen
- (2016) S. Khodavaisy et al. JOURNAL DE MYCOLOGIE MEDICALE
- Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections
- (2016) Hafize Sav et al. MYCOPATHOLOGIA
- Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
- (2016) Suganthini Krishnan Natesan et al. Infection and Drug Resistance
- In VitroActivities of Amphotericin B, Terbinafine, and Azole Drugs against Clinical and Environmental Isolates of Aspergillus terreus Sensu Stricto
- (2015) Mariana S. Fernández et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nationwide Surveillance of Azole Resistance in Aspergillus Diseases
- (2015) Edith Vermeulen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
- (2015) Paul E. Verweij et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections
- (2015) Ana C. Moreno-Rodríguez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds
- (2015) Frédéric Lamoth et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Secondary metabolite profiles and antifungal drug susceptibility of Aspergillus fumigatus and closely related species, Aspergillus lentulus, Aspergillus udagawae, and Aspergillus viridinutans
- (2015) Hiroyuki Tamiya et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases
- (2015) Francesco Barchiesi et al. LIVER TRANSPLANTATION
- In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex
- (2015) Hamid Badali et al. MYCOPATHOLOGIA
- Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses
- (2015) Yasemin Öz et al. MYCOPATHOLOGIA
- In vitroantifungal susceptibilities of isolates ofCandidaspp. andAspergillusspp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012
- (2015) Michael A. Pfaller et al. MYCOSES
- Molecular Identification and Amphotericin B Susceptibility Testing of Clinical Isolates ofAspergillusFrom 11 Hospitals in Korea
- (2015) Min Seok Heo et al. Annals of Laboratory Medicine
- Molecular Epidemiology and In-Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Isolates in Delhi, India: Evidence of Genetic Diversity by Amplified Fragment Length Polymorphism and Microsatellite Typing
- (2015) Shallu Kathuria et al. PLoS One
- Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands
- (2014) J. van Ingen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aspergillus citrinoterreus, a New Species of Section Terrei Isolated from Samples of Patients with Nonhematological Predisposing Conditions
- (2014) Jesús Guinea et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antifungal susceptibility of Aspergillus fumigatus clinical isolates collected from various areas in Japan
- (2014) Kazuyo Kikuchi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- The clinical spectrum of pulmonary aspergillosis
- (2014) C. Kosmidis et al. THORAX
- In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
- (2014) Soukeina Gheith et al. SpringerPlus
- Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
- (2013) A. Alastruey-Izquierdo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Pharmacodynamics of Amphotericin B against Aspergillus Species in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Rafal Al-Saigh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntifungal Susceptibility of Clinically Relevant Species Belonging to Aspergillus SectionFlavi
- (2013) Sarah S. Gonçalves et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole
- (2013) Lea Gregson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait
- (2013) Faten Al-Wathiqi et al. BMC INFECTIOUS DISEASES
- Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis
- (2013) F. Barchiesi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen?
- (2013) Kyung J. Kwon-Chung et al. PLoS Pathogens
- Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes inFusarium,Aspergillusand, Dematiaceous Keratitis
- (2013) Devarshi U. Gajjar et al. Biomed Research International
- Experimental Central Nervous System Aspergillosis Therapy: Efficacy, Drug Levels and Localization, Immunohistopathology, and Toxicity
- (2012) Karl V. Clemons et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies
- (2012) Camilla Colozza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Amphotericin Bin vitroresistance is associated with fatalAspergillus flavusinfection
- (2012) Inès Hadrich et al. MEDICAL MYCOLOGY
- Cryptic Species and Azole Resistance in the Aspergillus niger Complex
- (2011) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan
- (2011) Masato Tashiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polyphasic Identification and Susceptibility to Seven Antifungals of 102 Aspergillus Isolates Recovered from Immunocompromised Hosts in Greece
- (2011) Michael Arabatzis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activities of Anidulafungin and Other Antifungal Agents against Biofilms Formed by Clinical Isolates of Different Candida and Aspergillus Species
- (2011) Barbara Fiori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods
- (2011) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B
- (2011) P. Escribano et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2011) Shivaprakash M. Rudramurthy et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
- (2011) K. L. Mortensen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Molecular characterization of drug-resistant and drug-sensitive Aspergillus isolates causing infectious keratitis
- (2011) Niranjan Nayak et al. INDIAN JOURNAL OF OPHTHALMOLOGY
- In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs
- (2011) M. R. Shivaprakash et al. MYCOSES
- Microbial pathogens in the fungal kingdom
- (2011) Joseph Heitman Fungal Biology Reviews
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
- (2010) K. L. Mortensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitrosusceptibility testing inAspergillusspecies: an update
- (2010) Cornelia Lass-Flörl Future Microbiology
- Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy
- (2010) Adelina Amorim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan
- (2010) Toshikazu Yamazaki et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitroactivity of nine antifungal agents against clinical isolates ofAspergillus calidoustus
- (2010) Ana Alastruey-Izquierdo et al. MEDICAL MYCOLOGY
- Correlation of Proteinase Production with Amphotericin B Resistance in Fungi from Mycotic Keratitis
- (2010) N. Nayak et al. OPHTHALMIC RESEARCH
- A re-evaluation of random-effects meta-analysis
- (2008) Julian P. T. Higgins et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started